Working... Menu
Trial record 8 of 125 for:    lapatinib | Recruiting, Active, not recruiting, Completed Studies | Phase 2

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00470704
Recruitment Status : Active, not recruiting
First Posted : May 8, 2007
Last Update Posted : November 8, 2018
Information provided by (Responsible Party):
Nancy Lin, MD, Dana-Farber Cancer Institute